Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RNA
Biotech
Pfizer signs $331M deal with Ginkgo for unspecified targets
Ginkgo Bioworks will work with none other than Pfizer in a drug discovery deal for RNA medicines worth $331 million in biobucks for three programs.
Annalee Armstrong
Sep 27, 2023 9:50am
New RNA biotech raises $300M in largest private round of 2023
May 23, 2023 6:30am
Oncorus lays off 15% of workforce, drops solid tumor prospect
Nov 30, 2022 10:55am
Merck bets big on circular RNA, paying $150M to work with Orna
Aug 16, 2022 9:00am
Remix closes $70 million series B but what's in the pipeline?
May 17, 2022 6:45am
Remix Therapeutics signs licensure deal with Janssen topping $1B
Feb 17, 2022 7:00am